Variation in costs due to virtual switching from free- to fixed-triple LABA/LAMA/ICS combinations among COPD patients: an analysis using a primary care database-Reference-Cited by-同舟云学术

Variation in costs due to virtual switching from free- to fixed-triple LABA/LAMA/ICS combinations among COPD patients: an analysis using a primary care database

Published:2022-10-07 Issue:11 Volume:38 Page:1997-2001
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Lapi Francesco¹,Marconi Ettore¹,Lombardo Francesco Paolo²,Micheletto Claudio³,Cricelli Claudio²

Affiliation:

1. Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy

2. Italian College of General Practitioners and Primary Care, Florence, Italy

3. Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy

Funder

Italian College of General Practitioners and Primary Care

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2129229

Reference23 articles.

1. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. The impact of adherence to inhaled drugs on 5‐year survival in COPD patients: a time dependent approach

3. Poor adherence to chronic obstructive pulmonary disease medications in primary care: Role of age, disease burden and polypharmacy

4. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

5. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial